Current Neuropharmacology
Title:Meet Our Regional Editor
Volume: 16 Issue: 1
Author(s): Nobuhisa Iwata
Affiliation:
Export Options
About this article
Cite this article as:
Iwata Nobuhisa , Meet Our Regional Editor, Current Neuropharmacology 2018; 16 (1) . https://dx.doi.org/10.2174/1570159X1601171214093100
DOI https://dx.doi.org/10.2174/1570159X1601171214093100 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
26
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Suicide in Racial and Ethnic Minority Adults: A Review of the Last Decade
Current Psychiatry Reviews Combined Effect of Parthenolide and Various Anti-cancer Drugs or Anticancer Candidate Substances on Malignant Cells in vitro and in vivo
Mini-Reviews in Medicinal Chemistry An Overall Picture of Chemokine Receptors: Basic Research and Drug Development
Current Pharmaceutical Design Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Editorial [The Multifactorial Nature of Alzheimers Disease and Related Therapeutic Strategies (Executive Editors: Maria do Carmo Carreiras and Jose Marco-Contelles)]
Current Pharmaceutical Design What Have We Learned from the Novel Human Cytochromes P450 Hidden in the Databases?
Current Genomics Elucidation of the Chromatographic Enantiomer Elution Order Through Computational Studies
Mini-Reviews in Medicinal Chemistry Aerobic Exercise Does Not Predict Brain Derived Neurotrophic Factor And Cortisol Alterations in Depressed Patients
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Youth at Risk for Psychosis (Guest Editors: Steven Adelsheim and David Graeber)]
Adolescent Psychiatry Conference Report: Nanotechnology Congress & Expo 2015, Frankfurt, Germany August 11-13, 2015
CNS & Neurological Disorders - Drug Targets PLA2G6 Mutations and Other Rare Causes of Neurodegeneration with Brain Iron Accumulation
Current Drug Targets From The Editors Perspective: Unlocking the Secrets to Cell Survival and Longevity
Current Neurovascular Research Spinal Microvascular Expression of PV-1 is Associated with Inflammation, Perivascular Astrocyte Loss, and Diminished EC Glucose Transport Potential in Acute SCI
Current Neurovascular Research Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD)
CNS & Neurological Disorders - Drug Targets Meet Our Co-Editor
Current Enzyme Inhibition IDO+ DCs and Signalling Pathways
Current Cancer Drug Targets The Nature and Implications of Implicit Weight Bias
Current Psychiatry Reviews Stimulating Effects of H1-Antagonists
Current Pharmaceutical Design Targeting the Role of Astrocytes in the Progression of Alzheimers Disease
Current Signal Transduction Therapy New Insights into the Molecular Resistance Mechanisms of Chronic Myeloid Leukemia
Current Cancer Drug Targets